BLOOD, LYMPH AND RELATED CONDITIONS:@0.084848:0.038601:0.564720:0.038601:0.564720:0.019343:0.084848:0.019343:0.013500:0.010866:0.020438:0.020438:0.017498:0.006515:0.006515:0.008735:0.013923:0.021613:0.013923:0.016063:0.006515:0.017404:0.017404:0.017498:0.006515:0.014276:0.012606:0.010866:0.015466:0.010019:0.012606:0.017498:0.006515:0.019121:0.020438:0.017404:0.017498:0.005315:0.010019:0.005315:0.020438:0.017404:0.011712
84:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
14.   Pui CH. Recent research advances in child-:@0.084848:0.094740:0.475770:0.094740:0.475770:0.080735:0.084848:0.080735:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010126:0.010399:0.003421:0.004139:0.013906:0.011682:0.004738:0.004139:0.010382:0.011118:0.011067:0.011118:0.010434:0.005798:0.004126:0.005077:0.011118:0.006636:0.011118:0.011682:0.005030:0.011067:0.010434:0.004139:0.011682:0.011716:0.009476:0.011682:0.010434:0.011067:0.011118:0.006636:0.004139:0.003421:0.010434:0.004139:0.011067:0.010434:0.003421:0.003421:0.011716:0.005679
hood acute lymphoblastic leukemia. :@0.121195:0.108921:0.431848:0.108921:0.431848:0.094916:0.121195:0.094916:0.010434:0.011203:0.011203:0.011716:0.005037:0.011682:0.011067:0.010399:0.005798:0.011118:0.005046:0.003421:0.009168:0.016044:0.011665:0.010434:0.011203:0.011665:0.003421:0.011682:0.006636:0.005798:0.003421:0.011067:0.005058:0.003421:0.011118:0.010399:0.008586:0.011118:0.016044:0.003421:0.011682:0.004738:0.004738
J For-:@0.432156:0.108921:0.475751:0.108921:0.475751:0.094916:0.432156:0.094916:0.008244:0.005046:0.008296:0.011203:0.005128:0.005679
mos Med Assoc.:@0.121195:0.123103:0.256046:0.123103:0.256046:0.109098:0.121195:0.109098:0.016044:0.011203:0.006636:0.004738:0.015719:0.011118:0.011716:0.004738:0.012657:0.006636:0.006636:0.011203:0.011067:0.004738
 2010;109(11):777-787.:@0.256029:0.123103:0.435419:0.123103:0.435419:0.109098:0.256029:0.109098:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
15.   Larson S, Stock W. Progress in the treatment :@0.084848:0.137285:0.480520:0.137285:0.480520:0.123280:0.084848:0.123280:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.007902:0.011682:0.005148:0.006636:0.011203:0.010434:0.004539:0.008518:0.004738:0.004550:0.008518:0.005798:0.011203:0.011067:0.008586:0.004539:0.015149:0.004738:0.004550:0.010126:0.005075:0.011203:0.011511:0.005071:0.011118:0.006636:0.006636:0.004550:0.003421:0.010434:0.004550:0.005798:0.010434:0.011118:0.004539:0.005798:0.005075:0.011118:0.011682:0.005798:0.016044:0.011118:0.010434:0.005798:0.004738
of  adults  with acute  lymphoblastic leuke-:@0.121195:0.151466:0.475765:0.151466:0.475765:0.137461:0.121195:0.137461:0.011203:0.005371:0.004738:0.002947:0.011682:0.011716:0.010399:0.003421:0.005798:0.006636:0.004738:0.002951:0.014214:0.003421:0.005798:0.010434:0.007697:0.011682:0.011067:0.010399:0.005798:0.011118:0.004738:0.002947:0.003421:0.009168:0.016044:0.011665:0.010434:0.011203:0.011665:0.003421:0.011682:0.006648:0.005798:0.003421:0.011067:0.007697:0.003421:0.011118:0.010399:0.008586:0.011118:0.005679
mia. :@0.121195:0.165648:0.161818:0.165648:0.161818:0.151643:0.121195:0.151643:0.016044:0.003421:0.011682:0.004738:0.004738
Current Opinion in Hematology.:@0.162519:0.165648:0.427656:0.165648:0.427656:0.151643:0.162519:0.151643:0.013906:0.010399:0.005148:0.005148:0.011118:0.010434:0.005798:0.005434:0.014864:0.011665:0.003421:0.010434:0.003421:0.011203:0.010434:0.005439:0.003421:0.010434:0.005446:0.011682:0.011118:0.016044:0.011682:0.005798:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738
 2008, :@0.427656:0.165648:0.480479:0.165648:0.480479:0.151643:0.427656:0.151643:0.005444:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
15:400-407.:@0.121195:0.179830:0.212156:0.179830:0.212156:0.165825:0.121195:0.165825:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
16.   Bleckmann  K,  Schrappe  M.  Advances  in :@0.084848:0.194011:0.480493:0.194011:0.480493:0.180006:0.084848:0.180006:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.009818:0.003421:0.011118:0.011067:0.008586:0.016044:0.011682:0.010434:0.010434:0.004738:0.004608:0.010109:0.004738:0.004738:0.004601:0.008518:0.011067:0.010434:0.005148:0.011682:0.011665:0.011665:0.011118:0.004738:0.004606:0.015719:0.004738:0.004738:0.004604:0.012657:0.011716:0.009476:0.011682:0.010434:0.011067:0.011118:0.006636:0.004738:0.004606:0.003421:0.010434:0.004738
therapy for  Philadelphia-positive acute :@0.121195:0.208193:0.480501:0.208193:0.480501:0.194188:0.121195:0.194188:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.015599:0.005371:0.011203:0.005148:0.004738:0.010853:0.010126:0.010434:0.003421:0.003421:0.011682:0.011716:0.011118:0.003421:0.011665:0.010434:0.003421:0.011682:0.005679:0.011665:0.011203:0.006636:0.003421:0.005798:0.003421:0.009496:0.011118:0.015599:0.011682:0.011067:0.010399:0.005798:0.011118:0.004738
lymphoblastic leukaemia of childhood and :@0.560589:0.094693:0.919881:0.094693:0.919881:0.080687:0.560589:0.080687:0.003421:0.009168:0.016044:0.011665:0.010434:0.011203:0.011665:0.003421:0.011682:0.006636:0.005798:0.003421:0.011067:0.004120:0.003421:0.011118:0.010399:0.008586:0.011682:0.011118:0.016044:0.003421:0.011682:0.004105:0.011203:0.005371:0.004105:0.011067:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.004105:0.011682:0.010434:0.011716:0.004738
adolescence. :@0.560589:0.110909:0.680644:0.110909:0.680644:0.096903:0.560589:0.096903:0.011682:0.011716:0.011203:0.003421:0.011118:0.006636:0.011067:0.011118:0.010434:0.011067:0.011118:0.004738:0.004738
Br J Haematol.:@0.680901:0.110909:0.801504:0.110909:0.801504:0.096903:0.680901:0.096903:0.009818:0.005148:0.005012:0.008244:0.005012:0.011682:0.011682:0.011118:0.016044:0.011682:0.005798:0.011203:0.003421:0.004738
 2016 Mar;172 :@0.801504:0.110909:0.919893:0.110909:0.919893:0.096903:0.801504:0.096903:0.005012:0.009476:0.009476:0.009486:0.009476:0.005012:0.015719:0.011682:0.005148:0.004738:0.009476:0.009476:0.009476:0.004738
(6):855-69.:@0.560589:0.127125:0.645221:0.127125:0.645221:0.113120:0.560589:0.113120:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
17.   El Fakih R, Ahmed S, Alfraih F, :@0.524242:0.143341:0.809204:0.143341:0.809204:0.129336:0.524242:0.129336:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.009168:0.003421:0.005918:0.008296:0.011682:0.008586:0.003421:0.010434:0.005908:0.010382:0.004738:0.005906:0.012657:0.010434:0.016044:0.011118:0.011716:0.005901:0.008518:0.004738:0.005908:0.012657:0.003421:0.005371:0.005148:0.011682:0.003421:0.010434:0.005906:0.006205:0.004738:0.004738
et al.:@0.810364:0.143341:0.853026:0.143341:0.853026:0.129336:0.810364:0.129336:0.011118:0.005798:0.005904:0.011682:0.003421:0.004738
 Hema- :@0.853026:0.143341:0.919878:0.143341:0.919878:0.129336:0.853026:0.129336:0.005910:0.011682:0.011118:0.016044:0.011682:0.005679:0.004738
topoietic  cell transplantation for  acute :@0.560589:0.159557:0.919899:0.159557:0.919899:0.145552:0.560589:0.145552:0.005798:0.011203:0.011665:0.011203:0.003421:0.011118:0.005798:0.003421:0.011067:0.004738:0.008715:0.011067:0.011118:0.003421:0.003421:0.013461:0.005798:0.005148:0.011682:0.010434:0.006636:0.011665:0.003421:0.011682:0.010434:0.005798:0.011682:0.005798:0.003421:0.011203:0.010434:0.013461:0.005371:0.011203:0.005148:0.004738:0.008713:0.011682:0.011067:0.010399:0.005798:0.011118:0.004738
lymphoblastic  leukemia in adult patients. :@0.560589:0.175773:0.919880:0.175773:0.919880:0.161768:0.560589:0.161768:0.003421:0.009168:0.016044:0.011665:0.010434:0.011203:0.011665:0.003421:0.011682:0.006636:0.005798:0.003421:0.011067:0.004738:0.004016:0.003421:0.011118:0.010399:0.008586:0.011118:0.016044:0.003421:0.011682:0.008740:0.003421:0.010434:0.008740:0.011682:0.011716:0.010399:0.003421:0.005798:0.008740:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.004738
Hematol Oncol Stem Cell Ther.:@0.560589:0.191989:0.823261:0.191989:0.823261:0.177984:0.560589:0.177984:0.011682:0.011118:0.016044:0.011682:0.005798:0.011203:0.003421:0.007167:0.014864:0.010434:0.011067:0.011203:0.003421:0.007167:0.008518:0.005798:0.011118:0.016044:0.007167:0.013906:0.011118:0.003421:0.003421:0.007167:0.007286:0.010434:0.011118:0.005148:0.004738
 2017 Dec; :@0.823261:0.191989:0.919899:0.191989:0.919899:0.177984:0.823261:0.177984:0.007167:0.009476:0.009476:0.009476:0.009476:0.007182:0.012726:0.011118:0.011067:0.004738:0.004738
10(4):252-258.:@0.560589:0.208205:0.673649:0.208205:0.673649:0.194200:0.560589:0.194200:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738